BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17006704)

  • 1. Does cyclically iloprost infusion prevent severe isolated pulmonary hypertension in systemic sclerosis? Preliminary results.
    Caramaschi P; Volpe A; Tinazzi I; Bambara LM; Carletto A; Biasi D
    Rheumatol Int; 2006 Dec; 27(2):203-5. PubMed ID: 17006704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term evaluation of lung function in patients affected by scleroderma treated with cyclic iloprost infusions.
    Caramaschi P; Biasi D; Ferrari M; Volpe A; Martinelli N; Carletto A; Dal Forno P; Bambara LM
    Rheumatol Int; 2005 May; 25(4):250-4. PubMed ID: 14963694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost.
    Caramaschi P; Dalla Gassa A; Prati D; Barausse G; Tinazzi I; Ravagnani V; Confente S; Biasi D
    Rheumatol Int; 2012 Jul; 32(7):1933-8. PubMed ID: 21448643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent iloprost infusion therapy of pulmonary hypertension in scleroderma--a pilot study.
    Bartosik I; Eskilsson J; Scheja A; Akesson A
    Br J Rheumatol; 1996 Nov; 35(11):1187-8. PubMed ID: 8948314
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained success of therapy with inhaled iloprost for severe pulmonary arterial hypertension associated with systemic sclerosis and pulmonary fibrosis.
    Ahmadi-Simab K; Köhler A; Gross WL
    Clin Exp Rheumatol; 2007; 25(5):760-2. PubMed ID: 18078629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical stabilization of scleroderma patients treated with a chronic and intensive IV iloprost regimen.
    Foti R; Visalli E; Amato G; Benenati A; Converso G; Farina A; Bellofiore S; Mulè M; Di Gangi M
    Rheumatol Int; 2017 Feb; 37(2):245-249. PubMed ID: 27796521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized iloprost in CREST syndrome related pulmonary hypertension.
    Launay D; Hachulla E; Hatron PY; Goullard L; Onimus T; Robin S; Fauchais AL; Queyrel V; Michon-Pasturel U; Hebbar M; Saulnier F; Devulder B
    J Rheumatol; 2001 Oct; 28(10):2252-6. PubMed ID: 11669165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease.
    Caravita S; Wu SC; Secchi MB; Dadone V; Bencini C; Pierini S
    Eur J Intern Med; 2011 Oct; 22(5):518-21. PubMed ID: 21925064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension secondary to systemic lupus erythematosus: prolonged survival following treatment with intermittent low dose iloprost.
    Mok MY; Tse HF; Lau CS
    Lupus; 1999; 8(4):328-31. PubMed ID: 10413214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
    Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
    Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases].
    Nikolaeva EV; Yudkina NN; Kurmukov IA; Novikova DS; Markelova EI; Volkov AV
    Ter Arkh; 2015; 87(5):24-32. PubMed ID: 26155616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis with pulmonary hypertension.
    Rolla G; Colagrande P; Brussino L; Bucca C; Bertero MT; Caligaris-Cappio F
    Lancet; 1998 May; 351(9114):1491-2. PubMed ID: 9605813
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease.
    Hallioglu O; Dilber E; Celiker A
    Am J Cardiol; 2003 Oct; 92(8):1007-9. PubMed ID: 14556887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group.
    Airò P; Rossi M; Scarsi M; Danieli E; Grottolo A; Zambruni A
    Clin Exp Rheumatol; 2007; 25(5):722-7. PubMed ID: 18078620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of diffuse systemic sclerosis treated with a 28-day infusion of iloprost.
    Biasi D; Caramaschi P; Carletto A; Zeminian S; Schiavon F; Bambara LM
    Clin Rheumatol; 1997 Jan; 16(1):111-2. PubMed ID: 9132317
    [No Abstract]   [Full Text] [Related]  

  • 18. Iloprost infusion does not reduce oxidative stress in systemic sclerosis.
    Volpe A; Biasi D; Caramaschi P; Bambara LM; Carletto A; Degan M; Minuz P
    Rheumatol Int; 2008 Feb; 28(4):335-7. PubMed ID: 17704920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of prostacyclin for pulmonary hypertension in congenital heart disease.
    Durongpisitkul K; Jakrapanichakul D; Laohaprasitiporn D; Soongswang J; Chanthong P; Nana A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S60-5. PubMed ID: 16856428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.